|
Age, median (IQR), years
|
80 (76–81)
|
80 (78–83)
|
78 (74–81)
|
|
Gender, male (number, %)
|
7 (87.5%)
|
3 (75%)
|
4 (100%)
|
|
Height, median (IQR), cm
|
167 (153–170)
|
167 (149–172)
|
166 (153–170)
|
|
Weight, median (IQR), kg
|
56 (46–71)
|
51 (44–58)
|
65 (48–82)
|
|
Body mass index, median (IQR), kg/m2
|
20.5 (15.1–25.6)
|
17.1 (14.4–20.9)
|
25.2 (19.1–28.5)
|
|
Source of sepsis, n, (%)
|
|
Intrathoracic
|
2 (25%)
|
1 (25%)
|
1 (25%)
|
|
Intraabdominal
|
4 (50%)
|
3 (75%)
|
1 (25%)
|
|
Urogenital
|
1 (25%)
|
0 (0%)
|
1 (25%)
|
|
Skin/soft tissue/bone/joint
|
1 (25%)
|
0 (0%)
|
1 (25%)
|
|
APACHE II score, median (IQR)
|
21 (16–26)
|
23 (14–28)
|
19 (16–25)
|
|
SOFA score, median (IQR)
|
11 (9–13)
|
12 (10–14)
|
10 (8–13)
|
|
ICU stay, median (IQR), day
|
4.5 (4.0–27.8)
|
7 (4.3–30.8)
|
4.0 (4.0–26.5)
|
|
Hospital mortality, n, (%)
|
5 (62.5%)
|
3 (75%)
|
2 (50%)
|
|
Acute kidney injury, n, (%)
|
3 (37.5%)
|
1 (25%)
|
2 (50%)
|
|
Lactate, median (IQR), mg/dL
|
34.7 (19.0–65.7)
|
45.7 (27.3–65.7)
|
22.0 (15.0–181.1)
|
|
Procalcitonin, median (IQR), ng/mL
|
5.2 (3.8–17.2)
|
12.8 (4.8–46.7)
|
4.2 (1.5–8.3)
|
|
Glasgow Coma Scale, median (IQR)
|
13 (6–15)
|
10 (4–15)
|
14 (8–15)
|
|
Noradrenaline, median (IQR), μg/kg/min
|
0.3 (0.2–0.35)
|
0.28 (0.20–0.47)
|
0.30 (0.11–0.4)
|
